On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...

The world’s largest network of environmental groups approved the exploration of genetic engineering tools to aid in the ...

Colorectal cancer (CRC) remains one of the most prevalent cancers worldwide and a leading cause of cancer mortality. Despite ...

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...

Prosper Junior Bakiny has positions in Alphabet, Amazon, and Vertex Pharmaceuticals. The Motley Fool has positions in and ...

Cancer cells are known to reawaken embryonic genes to grow. A new study reveals the disease also hijacks the proteins, or "editors", that control how those genes are read.

Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...

Cellectis SA ( ($CLLS) ) has provided an announcement. On October 16, 2025, Cellectis hosted an R&D Day in New York City, where the company ...

Event features full Phase 1 data and pivotal Phase 2 strategy for lasme-cel (UCART22) in r/r B-ALLNEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- ...